Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of an Electronic Device Based Support Tool for ACS Patients: Brilique (Ticagrelor) Treatment Adherence (eMocial)

NCT02615704 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02615704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02615704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of an Electronic Device Based Support Tool for ACS Patients: Brilique (Ticagrelor) Treatment Adherence (eMocial)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 11, 2016
Completion date
March 7, 2019
Enrollment
677 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome